Patents by Inventor Pamela McGuiness

Pamela McGuiness has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Eponemycin and epoxomicin analogs and uses thereof
    Patent number: 7524883
    Abstract: The present invention provides compounds having formula (1): wherein R1-R6, A, J, D, E, G, Q, w, x, y, and z are as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof in the treatment of cancer and/or inflammatory disorders, and more generally as proteasome inhibitors.
    Type: Grant
    Filed: January 8, 2003
    Date of Patent: April 28, 2009
    Assignee: Eisai R&D Management Co., Ltd.
    Inventors: Sergei Agoulnik, Kozo Akasaka, Frank Fang, Jean-Christophe Harmange, Lynn Hawkins, Yimin Jiang, Charles Johannes, Xiang-Yi Li, Pamela McGuiness, Erin A. Murphy, Shawn Schiller, Mary Vermeulen, Jiayi Wu
  • Immunological adjuvant compounds compositions and methods of use thereof
    Patent number: 6551600
    Abstract: The present invention is directed to novel compounds that function as immunological adjuvants when co-administered with antigens such as vaccines for bacterial and viral diseases, to novel adjuvant formulations which include at least one of the adjuvant compounds of the invention, to novel immunostimulatory compositions which comprise an antigen and at least one of the adjuvant compounds of the invention, and to methods for the immunization of an animal by co-administration of a compound of the invention with an antigen against which the animal is to be immunized.
    Type: Grant
    Filed: July 31, 2001
    Date of Patent: April 22, 2003
    Assignee: Eisai Co., Ltd.
    Inventors: Lynn D. Hawkins, Sally T. Ishizaka, Michael Lewis, Pamela McGuiness, Jeffrey Rose
  • Immunological adjuvant compounds compositions and methods of use thereof
    Publication number: 20020049314
    Abstract: The present invention provides novel compounds that function as immunological adjuvants when co-administered with antigens, including, antigens used as vaccines for any disease or condition amenable to vaccination. The invention also provides adjuvant formulations comprising the novel compounds of the invention and methods for immunizing humans and non-human animals.
    Type: Application
    Filed: July 30, 2001
    Publication date: April 25, 2002
    Inventors: Lynn D. Hawkins, Sally T. Ishizaka, Michael Lewis, Pamela McGuiness, Jeffrey Rose
  • Immunological adjuvant compounds, compositions, and methods of use thereof
    Patent number: 6290973
    Abstract: The present invention is directed to novel compounds that function as immunological adjuvants when co-administered with antigens such as vaccines for bacterial and viral diseases, to novel adjuvant formulations which include at least one of the adjuvant compounds of the invention, to novel immunostimulatory compositions which comprise an antigen and at least one of the adjuvant compounds of the invention, and to methods for the immunization of an animal by co-administration of a compound of the invention with an antigen against which the animal is to be immunized.
    Type: Grant
    Filed: February 1, 2000
    Date of Patent: September 18, 2001
    Assignee: Eisai Co., Ltd.
    Inventors: Lynn D. Hawkins, Sally T. Ishizaka, Michael Lewis, Pamela McGuiness, Anneliese Nault, Jeffrey Rose, Daniel P. Rossignol